![](/img/cover-not-exists.png)
FDA Approval Summary: Olaparib Monotherapy in Patients with Deleterious Germline BRCA-Mutated Advanced Ovarian Cancer Treated with Three or More Lines of Chemotherapy
Kim, G., Ison, G., McKee, A. E., Zhang, H., Tang, S., Gwise, T., Sridhara, R., Lee, E., Tzou, A., Philip, R., Chiu, H.-J., Ricks, T. K., Palmby, T., Russell, A. M., Ladouceur, G., Pfuma, E., Li, H., ZLanguage:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-15-0887
Date:
July, 2015
File:
PDF, 214 KB
english, 2015